Clinical trial
Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD…
NCT00249093 · LHL Helse, Other · Completed
Key facts
| NCT number | NCT00249093 |
|---|---|
| Title | Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT |
| Lead sponsor | LHL Helse, Other |
| Collaborators | The norwegian association for heart and lung patients |
| Status | Completed |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | oxygen |
| Enrollment | 20 |
| Start date | Oct 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Nov 7, 2005 |
| Last update posted | Apr 13, 2007 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: